ImageneBio Inc (IMA) vs INmune Bio, Inc. (INMB)
A side-by-side comparison of ImageneBio Inc and INmune Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMA
ImageneBio Inc
$4.58HealthcareDelayed quote: Oct 6, 2026, 3:33 PM EDT
INMB
INmune Bio, Inc.
$1.83HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — IMA vs INMB
growth of $100 · dividends reinvested · last 6yIMA -98.8% (-52.0%/yr)INMB -84.3% (-26.6%/yr)INMB compounded faster over this window
Log scale — wide-divergence pair
IMA INMB
IMA vs INMB: by the numbers
- •IMA is the larger company ($52M vs $49M market cap).
- •Both run net losses; IMA's is the smaller (-5668.62% vs -91866.00% net margin).
Metrics side by side
Valuation
| Metric | IMA | INMB |
|---|---|---|
| P/B ratio | 0.36 | 2.39 |
Profitability
| Metric | IMA | INMB |
|---|---|---|
| Gross margin | -29.12% | 100.00% |
| Operating margin | -6056.37% | -61738.00% |
| Net margin | -5668.62% | -91866.00% |
| ROE | -36.94% | -90.44% |
| ROIC | -40.53% | -96.37% |
Growth (annualized)
| Metric | IMA | INMB |
|---|---|---|
| Total return CAGR (5Y) | -50.73% | -36.88% |
Frequently asked
- How have IMA and INMB total returns compared?
- Over the past 5 years, IMA delivered -50.73% and INMB delivered -36.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.